Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
<p>Abstract</p> <p>Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the tr...
Main Authors: | Kent David M, Rothwell Peter M, Ioannidis John PA, Altman Doug G, Hayward Rodney A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/11/1/85 |
Similar Items
-
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.
by: Kent, D, et al.
Published: (2010) -
Competing risk and heterogeneity of treatment effect in clinical trials
by: Alsheikh-Ali Alawi, et al.
Published: (2008-05-01) -
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials
by: Kent, D, et al.
Published: (2016) -
RISK HETEROGENEITY IN CLINICAL TRIALS: AN EVALUATION OF 25 LARGE CLINICAL TRIALS USING INDIVIDUAL PATIENT DATA
by: Kent, D, et al.
Published: (2014) -
Lead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials
by: Grimshaw Jeremy M, et al.
Published: (2006-03-01)